Occurrence of malignant tumours in the acute hepatic porphyrias

JIMD Reports

Volumn 22, Issue , 2015, Pages 17-22

  Lang, Estefanía ^a   Schäfer, Martin ^a   Schwender, Holger ^a   Neumann, Norbert J ^a   Frank, Jorge ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Acute hepatic porphyrias; Acute intermittent porphyria; Hepatocellular carcinoma; Hereditary coproporphyria; Porphyrias; Variegate porphyria; Aminolaevulinic acid dehydratase deficient porphyria

Indexed keywords

EID: 85051041235     PISSN: 21928304     EISSN: 21928312     Source Type: Book Series    
DOI: 10.1007/8904_2015_406     Document Type: Chapter

References (29)

1. Andant C, Puy H, Bogard C et al (2000) Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors. J Hepatol 32:933–939
2. Andersson C, Bjersing L, Lithner F (1996) The epidemiology of hepatocellular carcinoma in patients with acute intermittent porphyria. J Intern Med 240:195–201
3. Bengtsson NO, Hardell L (1986) Porphyrias, porphyrins and hepatocellular cancer. Br J Cancer 54:115–117
4. Cunningham D, Atkin W, Lenz H-J et al (2010) Colorectal cancer. Lancet 375:1030–1047. doi:10.1016/S0140-6736(10)60353-4
5. Davies JH, Whitaker SJ (2002) Chlorambucil and acute intermittent porphyria. Clin Oncol (R Coll Radiol) 14:491–493
6. Deybach J-C, Puy H (2011) Hepatocellular carcinoma without cirrhosis: think acute hepatic porphyrias and vice versa. J Intern Med 269:521–524. doi:10.1111/j.1365-2796.2011.02358.x
7. Elder G, Harper P, Badminton M et al (2013) The incidence of inherited porphyrias in Europe. J Inherit Metab Dis 36:849–857. doi:10.1007/s10545-012-9544-4
8. Fattovich G, Stroffolini T, Zagni I, Donato F (2004) Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127:S35–S50
9. Forget F, Awada A, Klastersky J (2001) Anticancer chemotherapy in a patient with prior history of acute intermittent porphyria. A case report and review of the literature. Support Care Cancer 9:465–466
10. Grabczynska SA, McGregor JM, Hawk JL (1996) Late onset variegate porphyria. Clin Exp Dermatol 21:353–356
11. Hanneken S, Kuerten V, Hoernke M, Neumann NJ (2009) Metastatic colon cancer triggering an acute attack of variegate porphyria. Int J Colorectal Dis 24:127–128. doi:10.1007/s00384-008-0537-6
12. Hardell L, Bengtsson NO, Jonsson U et al (1984) Aetiological aspects on primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria–an epidemiological investigation. Br J Cancer 50:389–397
13. Innala E, Andersson C (2011) Screening for hepatocellular carcinoma in acute intermittent porphyria: a 15-year follow-up in northern Sweden. J Intern Med 269:538–545. doi:10.1111/j.1365-2796.2010.02335.x
14. Kauppinen R, Mustajoki P (1988) Acute hepatic porphyria and hepatocellular carcinoma. Br J Cancer 57:117–120
15. Kristiansen C, Langkjer ST (2006) Treatment and treatment considerations in a patient with advanced breast cancer and acute intermittent porphyria. Acta Oncol 45:337–339. doi:10.1080/02841860500434697
16. Linet MS, Gridley G, Nyrén O et al (1999) Primary liver cancer, other malignancies, and mortality risks following porphyria: a cohort study in Denmark and Sweden. Am J Epidemiol 149:1010–1015
17. Lithner F, Wetterberg L (1984) Hepatocellular carcinoma in patients with acute intermittent porphyria. Acta Med Scand 215:271–274
18. Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362:1907–1917. doi:10.1016/S0140-6736(03)14964-1
19. Mañas Gómez MJ, GonzÄlez O, Vilallonga R, Armengol Carrasco M (2011) Severe hyponatremia in postoperatory of papillary thyroid carcinoma as a manifestation of acute intermittent porphyria. Med Clin (Barc) 136:556–557. doi:10.1016/j.med-cli.2010.09.037
20. Mendy M, Walton R (2009) Molecular pathogenesis and early detection of hepatocellular carcinoma–perspectives from West Africa. Cancer Lett 286:44–51. doi:10.1016/j.canlet.2009.04.039
21. Mullhaupt B, Junker C, Wuest E, Renner EL (2008) Mortality from primary liver cancer in Switzerland from 1975 to 1994. Swiss Med Week 138:313–316
22. Nordenstedt H, White DL, El-Serag HB (2010) The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis 42 (Suppl 3):S206–S214. doi:10.1016/S1590-8658(10)60507-5
23. Sardh E, Wahlin S, Björnstedt M et al (2013) High risk of primary liver cancer in a cohort of 179 patients with Acute Hepatic Porphyria. J Inherit Metab Dis 36:1063–1071. doi:10.1007/s10545-012-9576-9
24. Scarlett JD, Corry J, Jeal PN (1995) Cytotoxic chemotherapy and radiotherapy in a patient with breast cancer and variegate porphyria (VP). Aust N Z J Med 25:742–743
25. Schaffer M, Schaffer PM, Panzer M et al (2001) Porphyrias associated with malignant tumors: results of treatment with ionizing irradiation. Onkologie 24:170–172
26. Schneider-Yin X, Harms J, Minder EI (2009) Porphyria in Switzerland, 15 years experience. Swiss Med Week 139:198–206
27. Tidman MJ, Higgins EM, Elder GH, MacDonald DM (1989) Variegate porphyria associated with hepatocellular carcinoma. Br J Dermatol 121:503–505
28. Ulm K (1990) A simple method to calculate the confidence interval of a standardized mortality ratio (SMR). Am J Epidemiol 131:373–375
29. Zhou Y-M, Zhang X-F, Li B et al (2014) Prognosis after resection of hepatitis B virus-related hepatocellular carcinoma originating from non-cirrhotic liver. Ann Surg Oncol. doi:10.1245/s10434-014-3505-0